1. Jingshi Wang,Rui Zhang, Xiaoyan Wu, Fei Li, Haixia Yang,Ligen Liu,Haixia Guo, Xuejun Zhang,Huirong Mai,Hui Li,Zhao Wang*.Ruxolitinib-combined doxorubicin-etoposide-methylprednisolone regimen as a salvage therapy for refractory/relapsed haemophagocytic lymphohistiocytosis: a single-arm, multicentre, phase 2 trial.Br J Haematol.2021.193(4).761-768.SCI |
2. Jingshi Wang, Yini Wang, Lin Wu, Xinkai Wang, Zhili Jin, Zhuo Gao, Zhao Wang*.Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis .haematologica.2020.105.210-212.SCI |
3. Jingshi Wang, Houzhen Tuo, Lin Wu, Xinkai Wang , Zhao Wang*.Neurological symptoms of familial hemophagocytic lymphohistiocytosis type 2.Journal of Integrative Neuroscience.2020.19(1).131-135.SCI |
4. 王晶石,王旖旎,吴林,赖雯苑,王昭*.芦可替尼挽救治疗难治/复发噬血细胞综合征三例并文献复习.中华血液学杂志.2019.40(1).74-76.核心期刊 |
5. Jingshi Wang, Wei Han, Zhuo Gao, Yini Wang, Lin Wu, Jia Zhang, Wenyuan Lai, Zhao Wang*.Elevation of CD16+CD56+ NK-cells and downregulation of serum interleukin-21 (IL-21) and IL-1α after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause.Hematology.2017.22(8).477-483.SCI |
6. Jingshi Wang, Yini Wang, Lin Wu, Jia Zhang, Wenyuan Lai , Zhao Wang*.PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Hematology & Oncology.2016.9.e84.SCI |